Voltage-gated potassium channel antibody-mediated syndromes: A spectrum of clinical manifestations

Reviews in Neurological Diseases

Volumn 5, Issue 2, 2008, Pages 65-72

  Rueff, Laura ^a   Graber, Jerome J ^a   Bernbaum, Melissa ^a   Kuzniecky, Ruben I ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Limbic encephalitis; Morvan's syndrome; Neuromyotonia; Voltage gated potassium channel

Indexed keywords

ANTIBODY; VOLTAGE GATED POTASSIUM CHANNEL;

AUTONOMIC DYSFUNCTION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; HUMAN; MYOKYMIA; NEUROIMMUNOLOGY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PARANEOPLASTIC NEUROPATHY; PERIPHERAL NEUROPATHY; REVIEW; SYNDROME;

ANIMALS; ANTIBODIES; HUMANS; NERVOUS SYSTEM DISEASES; POTASSIUM CHANNELS, VOLTAGE-GATED;

EID: 46749098616     PISSN: 15452913     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Sinha S, Newsom-Davis J, Mills KR, et al. Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome). Lancet. 1991;338:75-77.
2. Schillito P, Molenaar PC, Vincent A, et al. Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol. 1995;38:714-722.
3. Newsom-Davis J. Autoimmune neuromyotonia (Issac's syndrome): an antibody-mediated potassium channelopathy. Ann N Y Acad Sci. 1997;835:111-119.
4. Hart IK, Waters C, Vincent A, et al. Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol. 1997;41:238-246.
5. Hart IK, Maddison P, Newsom-Davis J, et al. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain. 2002;125:1887-1895.
6. Vernino S, Lennon VA. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability. Muscle Nerve. 2002;26:702-707.
7. Newsom-Davis J, Buckley C, Clover L, et al. Autoimmune disorders of neuronal potassium channels. Ann N Y Acad Sci. 2003;998:202-210.
8. Buckley C, Oger J, Clover L, et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol. 2001;50:73-78.
9. Thieben MJ, Lennon VA, Boeve BF, et al. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology. 2004;62:1177-1182.
10. Vincent A, Buckley C, Schott J, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsivc form of limbic encephalitis. Brain. 2004;127:701-712.
11. Ances B, Vitaliani R, Taylor R, et al. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain. 2005;128:1764-1777.
12. Lee EK, Maselli RA, Ellis WG, Agius MA. Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma. J Neurol Neurosurg Psychiatry. 1998;65:857-862.
13. Barber PA, Anderson NE, Vincent A. Morvan's syndrome associated with voltage-gated K channel antibodies. Neurology. 2000;54:771.
14. Liguori R, Vincent A, Clover L, et al. Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain. 2001;124:2417-2426.
15. Diaz-Manera J, Rojas-Garcia R, Gallardo E, et al. Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome. Nat Clin Pract Neurol. 2007;3:405-410.
16. Josephs KA, Silber MH, Fealey RD, et al. Neurophysiologic studies in Morvan's syndrome. J Clin Neurophysiol. 2004;21:440-445.
17. Vincent A. Understanding neuromyotonia. Muscle Nerve. 2000;23:655-657.
18. Newsom-Davis J, Mills KR. Immunological associations of acquired neuromyotonia (Issacs' syndrome). Report of five cases and literature review. Brain. 1993;116:453-469.
19. Hart IK. Acquired neuromyotonia: a new autoantibody mediated neuronal potassium channelopathy. Am J Med Sci. 2000;319:209-216.
20. Dirr LY, Elster AD, Donofrio PD, Smith M. Evolution of brain MRI abnormalities in LE. Neurology. 1990;40:1304-1306.
21. Lawn ND, Westmorland BF, Kiely MJ, et al. Clinical, MRI and EEG findings in paraneoplastic limbic encephalitis. Mayo Clin Proc. 2003;78:1363-1368.
22. Fakhoury T, Abou-Khalil B, Kessler RM. Limbic encephalitis and hyperactive foci on PFT scan. Seizure. 1999;8:427-431.
23. Kassubek J, Juengling FD, Nitzsche EU, Lucking CH. Limbic encephalitis investigated by 18-FDG-PET and 3D MRI. J Neuroimaging. 2001;11:55-59.
24. Bataller L, Kleopa KA, Wu GF, et al. Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J Neurol Neurosurg Psychiatry. 2007;78:381-385.
25. Morvan A. De la choree fibrillaire. Gazette hebdomadaire de Médecine et de Chirurgie. 1890;27:173-176.
26. Halbach M, Homberg V, Freund HJ. Neuromuscular, autonomic and central cholinergic hyperactivity associated with thymoma and acetylcholine receptor-binding antibody. J Neurol. 1987;234:433-436.
27. Huag BA, Schoenle PW, Karch BJ, et al. Morvan's fibrillary chorea. A case with possible manganese poisoning. Clin Neurol Neurosurg. 1989;91:53-59.
28. Iwasaki Y, Kinoshita M, Ikeda K, et al. Concurrence of myasthenia gravis and choree fibrillaire de Morvan. Eur Arch Psychiatry Neurol Sci. 1990;239:335-336.
29. Madrid A, Gil-Peralta A, Gil-Neciga E, et al. Morvan's fibrillary chorea: remission after plasmapheresis. J Neurol. 243:350-353.
30. Vernay D, Dubost JJ, Thevenet JP, et al. "Choree fibrillaire de Morvan" followed by Guillain-Barre syndrome in a patient receiving gold therapy [letter]. Arthritis Rheum. 1986;29:1413-1414.
31. Cottrell DA, Blackmore KJ, Fawcett PR, et al. Sub-acute presentation of Morvan's syndrome after thymectomy. J Neurol Neurosurg Psychiatry. 2004;75:1504-1505.
32. Bajaj BK, Shrestha S. An interesting case report of Morvan's syndrome from the Indian subcontinent. Neurology India. 2007;55:67-69.
33. Loscher W, Wanschitz J, Reiners K, Quasthoff S. Morvan's syndrome: clinical, laboratory, and in vitro electrophysiological studies. Muscle Nerve. 2004;30:157-163.
34. Maselli RA, Agius M, Lee E-K, et al. Morvan's fibrillary chorea: electrodiagnostic and in vitro microelectrode findings. Ann N Y Acad Sci. 1998;841:497-500.
35. Agius MA, Zhu S, Lee EK, et al. Antibodies to AChR, synapse-organizing proteins, titin, and other muscle proteins in Morvan's fibrillary chorea. Ann N Y Acad Sci. 1998;841:522-524.
36. Vetrugno R, Liguori R, Provini F, et al. Continuous motor unit activity syndromes: a video-polysomnographic study. Clin Neurophysiol. 2005;116:2533-2541.
37. Mochizuki Y, Mizutani T, Isozaki E, et al. Acute limbic encephalitis: a new entity? Neurosci Lett. 2006;394:5-8.
38. Wang H, Kunkel DD, Martin TM, et al. Heteromultimeric potassium channels in terminal and juxtaparanodal regions of neurons. Nature. 1993;365:75-79.
39. Tomimitsu H, Arimura K, Nagado T, et al. Mechanism of action of voltage-gated K+ channel antibodies in acquired neuromyotonia. Ann Neurol. 2004;56:440-444.
40. Sonoda Y, Arimura K, Kurono A, et al. Serum of Isaacs' syndrome suppresses potassium channels in PC-12 cell lines. Muscle Nerve. 1996;19:1439-1446.
41. Nagado T, Arimura K, Sonoda Y, et al. Potassium current suppression in patients with peripheral nerve hyper-excitability. Brain. 1999;122:2057-2066.
42. Golding NL, Jung H, Mickus T, Spruston N. Dendritic calcium spike initiation and repolarization are controlled by distinct potassium channel subtypes in CA1 pyramidal neurons. J Neurosci. 1999;19:8789-8798.
43. Hoffman DA, Magee JC, Colbert CM, Johnston DK. K+ channel regulation of signal propagation in dendrites of hippocampal pyramidal neurons. Nature. 1997;387:869-875.
44. Kleopa KA, Elman L, Lang B, et al. Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations. Brain. 2006;129:1570-1584.
45. Antozzi C, Binelli S, Frassoni C, et al. Immunotherapy responsive startle with antibodies to voltage gated potassium channels. J Neurol Neurosurg Psychiatry. 2007;78:1281-1290.
46. Gultekin SH, Rosenfeld MR, Voltz R, et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000;123:1481-1494.
47. Jarius S, Hoffmann L, Clover L, et al. CSF findings in patients with voltage gated potassium channel antibody associated limbic encephalitis. J Neurol Sci. 2008;268:74-77.
48. Jacob S, Irani SR, Rajabally YA, et al. Hypothermia in VGKC antibody-associated limbic encephalitis. J Neurol Neurosurg Psychiatry. 2008;79:202-204.
49. Chan D, Henley S, Rossor M, Warrington E. Extensive and temporally ungraded retrograde amnesia in encephalitis associated with antibodies to voltage-gated potassium channels. Arch Neurol. 2007;64:404-410.
50. Bien CG, Urbach H, Schramm J, et al. Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy. Neurology. 2007;69:1236-1244.
51. Schott JM, Harkness K, Barnes J, et al. Amnesia, cerebral atrophy, and autoimmunity. Lancet. 2003;361:1266.
52. Alamowitch S, Graus F, Uchuya M, et al. Limbic encephalitis and small cell lung cancer - clinical and immunological features. Brain. 1997;120:923-928.